Global Psychoactive Substances Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Psychoactive Substances market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Psychoactive Substances Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Psychoactive Substances market in any manner.
Global Psychoactive Substances Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Zynerba Pharmaceuticals
GW Pharmaceuticals PLC.
Enecta.
Teewinot Life Sciences
GD Pharma
Cape Bouvard Technologies Pty Ltd
AusCann Group Holdings Pty Ltd.
Cannabics Pharmaceuticals Inc.
Alpha-CAT
Tilray
Cyrelian Pty Ltd.
MedReleaf Australia
Market Segmentation (by Type)
Stimulants
Cannabinoids
Hallucinogens
Depressants
Market Segmentation (by Application)
Cancer
Neuropathic Disorders
Spasticity
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Psychoactive Substances Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Psychoactive Substances market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Psychoactive Substances Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Psychoactive Substances market in any manner.
Global Psychoactive Substances Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Zynerba Pharmaceuticals
GW Pharmaceuticals PLC.
Enecta.
Teewinot Life Sciences
GD Pharma
Cape Bouvard Technologies Pty Ltd
AusCann Group Holdings Pty Ltd.
Cannabics Pharmaceuticals Inc.
Alpha-CAT
Tilray
Cyrelian Pty Ltd.
MedReleaf Australia
Market Segmentation (by Type)
Stimulants
Cannabinoids
Hallucinogens
Depressants
Market Segmentation (by Application)
Cancer
Neuropathic Disorders
Spasticity
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Psychoactive Substances Market
- Overview of the regional outlook of the Psychoactive Substances Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Psychoactive Substances Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Psychoactive Substances
1.2 Key Market Segments
1.2.1 Psychoactive Substances Segment by Type
1.2.2 Psychoactive Substances Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PSYCHOACTIVE SUBSTANCES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Psychoactive Substances Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Psychoactive Substances Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PSYCHOACTIVE SUBSTANCES MARKET COMPETITIVE LANDSCAPE
3.1 Global Psychoactive Substances Sales by Manufacturers (2019-2024)
3.2 Global Psychoactive Substances Revenue Market Share by Manufacturers (2019-2024)
3.3 Psychoactive Substances Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Psychoactive Substances Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Psychoactive Substances Sales Sites, Area Served, Product Type
3.6 Psychoactive Substances Market Competitive Situation and Trends
3.6.1 Psychoactive Substances Market Concentration Rate
3.6.2 Global 5 and 10 Largest Psychoactive Substances Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PSYCHOACTIVE SUBSTANCES INDUSTRY CHAIN ANALYSIS
4.1 Psychoactive Substances Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PSYCHOACTIVE SUBSTANCES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PSYCHOACTIVE SUBSTANCES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Psychoactive Substances Sales Market Share by Type (2019-2024)
6.3 Global Psychoactive Substances Market Size Market Share by Type (2019-2024)
6.4 Global Psychoactive Substances Price by Type (2019-2024)
7 PSYCHOACTIVE SUBSTANCES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Psychoactive Substances Market Sales by Application (2019-2024)
7.3 Global Psychoactive Substances Market Size (M USD) by Application (2019-2024)
7.4 Global Psychoactive Substances Sales Growth Rate by Application (2019-2024)
8 PSYCHOACTIVE SUBSTANCES MARKET SEGMENTATION BY REGION
8.1 Global Psychoactive Substances Sales by Region
8.1.1 Global Psychoactive Substances Sales by Region
8.1.2 Global Psychoactive Substances Sales Market Share by Region
8.2 North America
8.2.1 North America Psychoactive Substances Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Psychoactive Substances Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Psychoactive Substances Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Psychoactive Substances Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Psychoactive Substances Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Zynerba Pharmaceuticals
9.1.1 Zynerba Pharmaceuticals Psychoactive Substances Basic Information
9.1.2 Zynerba Pharmaceuticals Psychoactive Substances Product Overview
9.1.3 Zynerba Pharmaceuticals Psychoactive Substances Product Market Performance
9.1.4 Zynerba Pharmaceuticals Business Overview
9.1.5 Zynerba Pharmaceuticals Psychoactive Substances SWOT Analysis
9.1.6 Zynerba Pharmaceuticals Recent Developments
9.2 GW Pharmaceuticals PLC.
9.2.1 GW Pharmaceuticals PLC. Psychoactive Substances Basic Information
9.2.2 GW Pharmaceuticals PLC. Psychoactive Substances Product Overview
9.2.3 GW Pharmaceuticals PLC. Psychoactive Substances Product Market Performance
9.2.4 GW Pharmaceuticals PLC. Business Overview
9.2.5 GW Pharmaceuticals PLC. Psychoactive Substances SWOT Analysis
9.2.6 GW Pharmaceuticals PLC. Recent Developments
9.3 Enecta.
9.3.1 Enecta. Psychoactive Substances Basic Information
9.3.2 Enecta. Psychoactive Substances Product Overview
9.3.3 Enecta. Psychoactive Substances Product Market Performance
9.3.4 Enecta. Psychoactive Substances SWOT Analysis
9.3.5 Enecta. Business Overview
9.3.6 Enecta. Recent Developments
9.4 Teewinot Life Sciences
9.4.1 Teewinot Life Sciences Psychoactive Substances Basic Information
9.4.2 Teewinot Life Sciences Psychoactive Substances Product Overview
9.4.3 Teewinot Life Sciences Psychoactive Substances Product Market Performance
9.4.4 Teewinot Life Sciences Business Overview
9.4.5 Teewinot Life Sciences Recent Developments
9.5 GD Pharma
9.5.1 GD Pharma Psychoactive Substances Basic Information
9.5.2 GD Pharma Psychoactive Substances Product Overview
9.5.3 GD Pharma Psychoactive Substances Product Market Performance
9.5.4 GD Pharma Business Overview
9.5.5 GD Pharma Recent Developments
9.6 Cape Bouvard Technologies Pty Ltd
9.6.1 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Basic Information
9.6.2 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Product Overview
9.6.3 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Product Market Performance
9.6.4 Cape Bouvard Technologies Pty Ltd Business Overview
9.6.5 Cape Bouvard Technologies Pty Ltd Recent Developments
9.7 AusCann Group Holdings Pty Ltd.
9.7.1 AusCann Group Holdings Pty Ltd. Psychoactive Substances Basic Information
9.7.2 AusCann Group Holdings Pty Ltd. Psychoactive Substances Product Overview
9.7.3 AusCann Group Holdings Pty Ltd. Psychoactive Substances Product Market Performance
9.7.4 AusCann Group Holdings Pty Ltd. Business Overview
9.7.5 AusCann Group Holdings Pty Ltd. Recent Developments
9.8 Cannabics Pharmaceuticals Inc.
9.8.1 Cannabics Pharmaceuticals Inc. Psychoactive Substances Basic Information
9.8.2 Cannabics Pharmaceuticals Inc. Psychoactive Substances Product Overview
9.8.3 Cannabics Pharmaceuticals Inc. Psychoactive Substances Product Market Performance
9.8.4 Cannabics Pharmaceuticals Inc. Business Overview
9.8.5 Cannabics Pharmaceuticals Inc. Recent Developments
9.9 Alpha-CAT
9.9.1 Alpha-CAT Psychoactive Substances Basic Information
9.9.2 Alpha-CAT Psychoactive Substances Product Overview
9.9.3 Alpha-CAT Psychoactive Substances Product Market Performance
9.9.4 Alpha-CAT Business Overview
9.9.5 Alpha-CAT Recent Developments
9.10 Tilray
9.10.1 Tilray Psychoactive Substances Basic Information
9.10.2 Tilray Psychoactive Substances Product Overview
9.10.3 Tilray Psychoactive Substances Product Market Performance
9.10.4 Tilray Business Overview
9.10.5 Tilray Recent Developments
9.11 Cyrelian Pty Ltd.
9.11.1 Cyrelian Pty Ltd. Psychoactive Substances Basic Information
9.11.2 Cyrelian Pty Ltd. Psychoactive Substances Product Overview
9.11.3 Cyrelian Pty Ltd. Psychoactive Substances Product Market Performance
9.11.4 Cyrelian Pty Ltd. Business Overview
9.11.5 Cyrelian Pty Ltd. Recent Developments
9.12 MedReleaf Australia
9.12.1 MedReleaf Australia Psychoactive Substances Basic Information
9.12.2 MedReleaf Australia Psychoactive Substances Product Overview
9.12.3 MedReleaf Australia Psychoactive Substances Product Market Performance
9.12.4 MedReleaf Australia Business Overview
9.12.5 MedReleaf Australia Recent Developments
10 PSYCHOACTIVE SUBSTANCES MARKET FORECAST BY REGION
10.1 Global Psychoactive Substances Market Size Forecast
10.2 Global Psychoactive Substances Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Psychoactive Substances Market Size Forecast by Country
10.2.3 Asia Pacific Psychoactive Substances Market Size Forecast by Region
10.2.4 South America Psychoactive Substances Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Psychoactive Substances by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Psychoactive Substances Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Psychoactive Substances by Type (2025-2030)
11.1.2 Global Psychoactive Substances Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Psychoactive Substances by Type (2025-2030)
11.2 Global Psychoactive Substances Market Forecast by Application (2025-2030)
11.2.1 Global Psychoactive Substances Sales (Kilotons) Forecast by Application
11.2.2 Global Psychoactive Substances Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Psychoactive Substances
1.2 Key Market Segments
1.2.1 Psychoactive Substances Segment by Type
1.2.2 Psychoactive Substances Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PSYCHOACTIVE SUBSTANCES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Psychoactive Substances Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Psychoactive Substances Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PSYCHOACTIVE SUBSTANCES MARKET COMPETITIVE LANDSCAPE
3.1 Global Psychoactive Substances Sales by Manufacturers (2019-2024)
3.2 Global Psychoactive Substances Revenue Market Share by Manufacturers (2019-2024)
3.3 Psychoactive Substances Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Psychoactive Substances Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Psychoactive Substances Sales Sites, Area Served, Product Type
3.6 Psychoactive Substances Market Competitive Situation and Trends
3.6.1 Psychoactive Substances Market Concentration Rate
3.6.2 Global 5 and 10 Largest Psychoactive Substances Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PSYCHOACTIVE SUBSTANCES INDUSTRY CHAIN ANALYSIS
4.1 Psychoactive Substances Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PSYCHOACTIVE SUBSTANCES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PSYCHOACTIVE SUBSTANCES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Psychoactive Substances Sales Market Share by Type (2019-2024)
6.3 Global Psychoactive Substances Market Size Market Share by Type (2019-2024)
6.4 Global Psychoactive Substances Price by Type (2019-2024)
7 PSYCHOACTIVE SUBSTANCES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Psychoactive Substances Market Sales by Application (2019-2024)
7.3 Global Psychoactive Substances Market Size (M USD) by Application (2019-2024)
7.4 Global Psychoactive Substances Sales Growth Rate by Application (2019-2024)
8 PSYCHOACTIVE SUBSTANCES MARKET SEGMENTATION BY REGION
8.1 Global Psychoactive Substances Sales by Region
8.1.1 Global Psychoactive Substances Sales by Region
8.1.2 Global Psychoactive Substances Sales Market Share by Region
8.2 North America
8.2.1 North America Psychoactive Substances Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Psychoactive Substances Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Psychoactive Substances Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Psychoactive Substances Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Psychoactive Substances Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Zynerba Pharmaceuticals
9.1.1 Zynerba Pharmaceuticals Psychoactive Substances Basic Information
9.1.2 Zynerba Pharmaceuticals Psychoactive Substances Product Overview
9.1.3 Zynerba Pharmaceuticals Psychoactive Substances Product Market Performance
9.1.4 Zynerba Pharmaceuticals Business Overview
9.1.5 Zynerba Pharmaceuticals Psychoactive Substances SWOT Analysis
9.1.6 Zynerba Pharmaceuticals Recent Developments
9.2 GW Pharmaceuticals PLC.
9.2.1 GW Pharmaceuticals PLC. Psychoactive Substances Basic Information
9.2.2 GW Pharmaceuticals PLC. Psychoactive Substances Product Overview
9.2.3 GW Pharmaceuticals PLC. Psychoactive Substances Product Market Performance
9.2.4 GW Pharmaceuticals PLC. Business Overview
9.2.5 GW Pharmaceuticals PLC. Psychoactive Substances SWOT Analysis
9.2.6 GW Pharmaceuticals PLC. Recent Developments
9.3 Enecta.
9.3.1 Enecta. Psychoactive Substances Basic Information
9.3.2 Enecta. Psychoactive Substances Product Overview
9.3.3 Enecta. Psychoactive Substances Product Market Performance
9.3.4 Enecta. Psychoactive Substances SWOT Analysis
9.3.5 Enecta. Business Overview
9.3.6 Enecta. Recent Developments
9.4 Teewinot Life Sciences
9.4.1 Teewinot Life Sciences Psychoactive Substances Basic Information
9.4.2 Teewinot Life Sciences Psychoactive Substances Product Overview
9.4.3 Teewinot Life Sciences Psychoactive Substances Product Market Performance
9.4.4 Teewinot Life Sciences Business Overview
9.4.5 Teewinot Life Sciences Recent Developments
9.5 GD Pharma
9.5.1 GD Pharma Psychoactive Substances Basic Information
9.5.2 GD Pharma Psychoactive Substances Product Overview
9.5.3 GD Pharma Psychoactive Substances Product Market Performance
9.5.4 GD Pharma Business Overview
9.5.5 GD Pharma Recent Developments
9.6 Cape Bouvard Technologies Pty Ltd
9.6.1 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Basic Information
9.6.2 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Product Overview
9.6.3 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Product Market Performance
9.6.4 Cape Bouvard Technologies Pty Ltd Business Overview
9.6.5 Cape Bouvard Technologies Pty Ltd Recent Developments
9.7 AusCann Group Holdings Pty Ltd.
9.7.1 AusCann Group Holdings Pty Ltd. Psychoactive Substances Basic Information
9.7.2 AusCann Group Holdings Pty Ltd. Psychoactive Substances Product Overview
9.7.3 AusCann Group Holdings Pty Ltd. Psychoactive Substances Product Market Performance
9.7.4 AusCann Group Holdings Pty Ltd. Business Overview
9.7.5 AusCann Group Holdings Pty Ltd. Recent Developments
9.8 Cannabics Pharmaceuticals Inc.
9.8.1 Cannabics Pharmaceuticals Inc. Psychoactive Substances Basic Information
9.8.2 Cannabics Pharmaceuticals Inc. Psychoactive Substances Product Overview
9.8.3 Cannabics Pharmaceuticals Inc. Psychoactive Substances Product Market Performance
9.8.4 Cannabics Pharmaceuticals Inc. Business Overview
9.8.5 Cannabics Pharmaceuticals Inc. Recent Developments
9.9 Alpha-CAT
9.9.1 Alpha-CAT Psychoactive Substances Basic Information
9.9.2 Alpha-CAT Psychoactive Substances Product Overview
9.9.3 Alpha-CAT Psychoactive Substances Product Market Performance
9.9.4 Alpha-CAT Business Overview
9.9.5 Alpha-CAT Recent Developments
9.10 Tilray
9.10.1 Tilray Psychoactive Substances Basic Information
9.10.2 Tilray Psychoactive Substances Product Overview
9.10.3 Tilray Psychoactive Substances Product Market Performance
9.10.4 Tilray Business Overview
9.10.5 Tilray Recent Developments
9.11 Cyrelian Pty Ltd.
9.11.1 Cyrelian Pty Ltd. Psychoactive Substances Basic Information
9.11.2 Cyrelian Pty Ltd. Psychoactive Substances Product Overview
9.11.3 Cyrelian Pty Ltd. Psychoactive Substances Product Market Performance
9.11.4 Cyrelian Pty Ltd. Business Overview
9.11.5 Cyrelian Pty Ltd. Recent Developments
9.12 MedReleaf Australia
9.12.1 MedReleaf Australia Psychoactive Substances Basic Information
9.12.2 MedReleaf Australia Psychoactive Substances Product Overview
9.12.3 MedReleaf Australia Psychoactive Substances Product Market Performance
9.12.4 MedReleaf Australia Business Overview
9.12.5 MedReleaf Australia Recent Developments
10 PSYCHOACTIVE SUBSTANCES MARKET FORECAST BY REGION
10.1 Global Psychoactive Substances Market Size Forecast
10.2 Global Psychoactive Substances Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Psychoactive Substances Market Size Forecast by Country
10.2.3 Asia Pacific Psychoactive Substances Market Size Forecast by Region
10.2.4 South America Psychoactive Substances Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Psychoactive Substances by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Psychoactive Substances Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Psychoactive Substances by Type (2025-2030)
11.1.2 Global Psychoactive Substances Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Psychoactive Substances by Type (2025-2030)
11.2 Global Psychoactive Substances Market Forecast by Application (2025-2030)
11.2.1 Global Psychoactive Substances Sales (Kilotons) Forecast by Application
11.2.2 Global Psychoactive Substances Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Psychoactive Substances Market Size Comparison by Region (M USD)
Table 5. Global Psychoactive Substances Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Psychoactive Substances Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Psychoactive Substances Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Psychoactive Substances Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychoactive Substances as of 2022)
Table 10. Global Market Psychoactive Substances Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Psychoactive Substances Sales Sites and Area Served
Table 12. Manufacturers Psychoactive Substances Product Type
Table 13. Global Psychoactive Substances Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Psychoactive Substances
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Psychoactive Substances Market Challenges
Table 22. Global Psychoactive Substances Sales by Type (Kilotons)
Table 23. Global Psychoactive Substances Market Size by Type (M USD)
Table 24. Global Psychoactive Substances Sales (Kilotons) by Type (2019-2024)
Table 25. Global Psychoactive Substances Sales Market Share by Type (2019-2024)
Table 26. Global Psychoactive Substances Market Size (M USD) by Type (2019-2024)
Table 27. Global Psychoactive Substances Market Size Share by Type (2019-2024)
Table 28. Global Psychoactive Substances Price (USD/Ton) by Type (2019-2024)
Table 29. Global Psychoactive Substances Sales (Kilotons) by Application
Table 30. Global Psychoactive Substances Market Size by Application
Table 31. Global Psychoactive Substances Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Psychoactive Substances Sales Market Share by Application (2019-2024)
Table 33. Global Psychoactive Substances Sales by Application (2019-2024) & (M USD)
Table 34. Global Psychoactive Substances Market Share by Application (2019-2024)
Table 35. Global Psychoactive Substances Sales Growth Rate by Application (2019-2024)
Table 36. Global Psychoactive Substances Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Psychoactive Substances Sales Market Share by Region (2019-2024)
Table 38. North America Psychoactive Substances Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Psychoactive Substances Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Psychoactive Substances Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Psychoactive Substances Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Psychoactive Substances Sales by Region (2019-2024) & (Kilotons)
Table 43. Zynerba Pharmaceuticals Psychoactive Substances Basic Information
Table 44. Zynerba Pharmaceuticals Psychoactive Substances Product Overview
Table 45. Zynerba Pharmaceuticals Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Zynerba Pharmaceuticals Business Overview
Table 47. Zynerba Pharmaceuticals Psychoactive Substances SWOT Analysis
Table 48. Zynerba Pharmaceuticals Recent Developments
Table 49. GW Pharmaceuticals PLC. Psychoactive Substances Basic Information
Table 50. GW Pharmaceuticals PLC. Psychoactive Substances Product Overview
Table 51. GW Pharmaceuticals PLC. Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GW Pharmaceuticals PLC. Business Overview
Table 53. GW Pharmaceuticals PLC. Psychoactive Substances SWOT Analysis
Table 54. GW Pharmaceuticals PLC. Recent Developments
Table 55. Enecta. Psychoactive Substances Basic Information
Table 56. Enecta. Psychoactive Substances Product Overview
Table 57. Enecta. Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Enecta. Psychoactive Substances SWOT Analysis
Table 59. Enecta. Business Overview
Table 60. Enecta. Recent Developments
Table 61. Teewinot Life Sciences Psychoactive Substances Basic Information
Table 62. Teewinot Life Sciences Psychoactive Substances Product Overview
Table 63. Teewinot Life Sciences Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Teewinot Life Sciences Business Overview
Table 65. Teewinot Life Sciences Recent Developments
Table 66. GD Pharma Psychoactive Substances Basic Information
Table 67. GD Pharma Psychoactive Substances Product Overview
Table 68. GD Pharma Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GD Pharma Business Overview
Table 70. GD Pharma Recent Developments
Table 71. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Basic Information
Table 72. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Product Overview
Table 73. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Cape Bouvard Technologies Pty Ltd Business Overview
Table 75. Cape Bouvard Technologies Pty Ltd Recent Developments
Table 76. AusCann Group Holdings Pty Ltd. Psychoactive Substances Basic Information
Table 77. AusCann Group Holdings Pty Ltd. Psychoactive Substances Product Overview
Table 78. AusCann Group Holdings Pty Ltd. Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. AusCann Group Holdings Pty Ltd. Business Overview
Table 80. AusCann Group Holdings Pty Ltd. Recent Developments
Table 81. Cannabics Pharmaceuticals Inc. Psychoactive Substances Basic Information
Table 82. Cannabics Pharmaceuticals Inc. Psychoactive Substances Product Overview
Table 83. Cannabics Pharmaceuticals Inc. Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Cannabics Pharmaceuticals Inc. Business Overview
Table 85. Cannabics Pharmaceuticals Inc. Recent Developments
Table 86. Alpha-CAT Psychoactive Substances Basic Information
Table 87. Alpha-CAT Psychoactive Substances Product Overview
Table 88. Alpha-CAT Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Alpha-CAT Business Overview
Table 90. Alpha-CAT Recent Developments
Table 91. Tilray Psychoactive Substances Basic Information
Table 92. Tilray Psychoactive Substances Product Overview
Table 93. Tilray Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Tilray Business Overview
Table 95. Tilray Recent Developments
Table 96. Cyrelian Pty Ltd. Psychoactive Substances Basic Information
Table 97. Cyrelian Pty Ltd. Psychoactive Substances Product Overview
Table 98. Cyrelian Pty Ltd. Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Cyrelian Pty Ltd. Business Overview
Table 100. Cyrelian Pty Ltd. Recent Developments
Table 101. MedReleaf Australia Psychoactive Substances Basic Information
Table 102. MedReleaf Australia Psychoactive Substances Product Overview
Table 103. MedReleaf Australia Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. MedReleaf Australia Business Overview
Table 105. MedReleaf Australia Recent Developments
Table 106. Global Psychoactive Substances Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Psychoactive Substances Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Psychoactive Substances Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Psychoactive Substances Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Psychoactive Substances Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Psychoactive Substances Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Psychoactive Substances Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Psychoactive Substances Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Psychoactive Substances Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Psychoactive Substances Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Psychoactive Substances Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Psychoactive Substances Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Psychoactive Substances Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Psychoactive Substances Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Psychoactive Substances Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Psychoactive Substances Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Psychoactive Substances Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Psychoactive Substances Market Size Comparison by Region (M USD)
Table 5. Global Psychoactive Substances Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Psychoactive Substances Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Psychoactive Substances Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Psychoactive Substances Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychoactive Substances as of 2022)
Table 10. Global Market Psychoactive Substances Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Psychoactive Substances Sales Sites and Area Served
Table 12. Manufacturers Psychoactive Substances Product Type
Table 13. Global Psychoactive Substances Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Psychoactive Substances
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Psychoactive Substances Market Challenges
Table 22. Global Psychoactive Substances Sales by Type (Kilotons)
Table 23. Global Psychoactive Substances Market Size by Type (M USD)
Table 24. Global Psychoactive Substances Sales (Kilotons) by Type (2019-2024)
Table 25. Global Psychoactive Substances Sales Market Share by Type (2019-2024)
Table 26. Global Psychoactive Substances Market Size (M USD) by Type (2019-2024)
Table 27. Global Psychoactive Substances Market Size Share by Type (2019-2024)
Table 28. Global Psychoactive Substances Price (USD/Ton) by Type (2019-2024)
Table 29. Global Psychoactive Substances Sales (Kilotons) by Application
Table 30. Global Psychoactive Substances Market Size by Application
Table 31. Global Psychoactive Substances Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Psychoactive Substances Sales Market Share by Application (2019-2024)
Table 33. Global Psychoactive Substances Sales by Application (2019-2024) & (M USD)
Table 34. Global Psychoactive Substances Market Share by Application (2019-2024)
Table 35. Global Psychoactive Substances Sales Growth Rate by Application (2019-2024)
Table 36. Global Psychoactive Substances Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Psychoactive Substances Sales Market Share by Region (2019-2024)
Table 38. North America Psychoactive Substances Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Psychoactive Substances Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Psychoactive Substances Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Psychoactive Substances Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Psychoactive Substances Sales by Region (2019-2024) & (Kilotons)
Table 43. Zynerba Pharmaceuticals Psychoactive Substances Basic Information
Table 44. Zynerba Pharmaceuticals Psychoactive Substances Product Overview
Table 45. Zynerba Pharmaceuticals Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Zynerba Pharmaceuticals Business Overview
Table 47. Zynerba Pharmaceuticals Psychoactive Substances SWOT Analysis
Table 48. Zynerba Pharmaceuticals Recent Developments
Table 49. GW Pharmaceuticals PLC. Psychoactive Substances Basic Information
Table 50. GW Pharmaceuticals PLC. Psychoactive Substances Product Overview
Table 51. GW Pharmaceuticals PLC. Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GW Pharmaceuticals PLC. Business Overview
Table 53. GW Pharmaceuticals PLC. Psychoactive Substances SWOT Analysis
Table 54. GW Pharmaceuticals PLC. Recent Developments
Table 55. Enecta. Psychoactive Substances Basic Information
Table 56. Enecta. Psychoactive Substances Product Overview
Table 57. Enecta. Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Enecta. Psychoactive Substances SWOT Analysis
Table 59. Enecta. Business Overview
Table 60. Enecta. Recent Developments
Table 61. Teewinot Life Sciences Psychoactive Substances Basic Information
Table 62. Teewinot Life Sciences Psychoactive Substances Product Overview
Table 63. Teewinot Life Sciences Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Teewinot Life Sciences Business Overview
Table 65. Teewinot Life Sciences Recent Developments
Table 66. GD Pharma Psychoactive Substances Basic Information
Table 67. GD Pharma Psychoactive Substances Product Overview
Table 68. GD Pharma Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GD Pharma Business Overview
Table 70. GD Pharma Recent Developments
Table 71. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Basic Information
Table 72. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Product Overview
Table 73. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Cape Bouvard Technologies Pty Ltd Business Overview
Table 75. Cape Bouvard Technologies Pty Ltd Recent Developments
Table 76. AusCann Group Holdings Pty Ltd. Psychoactive Substances Basic Information
Table 77. AusCann Group Holdings Pty Ltd. Psychoactive Substances Product Overview
Table 78. AusCann Group Holdings Pty Ltd. Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. AusCann Group Holdings Pty Ltd. Business Overview
Table 80. AusCann Group Holdings Pty Ltd. Recent Developments
Table 81. Cannabics Pharmaceuticals Inc. Psychoactive Substances Basic Information
Table 82. Cannabics Pharmaceuticals Inc. Psychoactive Substances Product Overview
Table 83. Cannabics Pharmaceuticals Inc. Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Cannabics Pharmaceuticals Inc. Business Overview
Table 85. Cannabics Pharmaceuticals Inc. Recent Developments
Table 86. Alpha-CAT Psychoactive Substances Basic Information
Table 87. Alpha-CAT Psychoactive Substances Product Overview
Table 88. Alpha-CAT Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Alpha-CAT Business Overview
Table 90. Alpha-CAT Recent Developments
Table 91. Tilray Psychoactive Substances Basic Information
Table 92. Tilray Psychoactive Substances Product Overview
Table 93. Tilray Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Tilray Business Overview
Table 95. Tilray Recent Developments
Table 96. Cyrelian Pty Ltd. Psychoactive Substances Basic Information
Table 97. Cyrelian Pty Ltd. Psychoactive Substances Product Overview
Table 98. Cyrelian Pty Ltd. Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Cyrelian Pty Ltd. Business Overview
Table 100. Cyrelian Pty Ltd. Recent Developments
Table 101. MedReleaf Australia Psychoactive Substances Basic Information
Table 102. MedReleaf Australia Psychoactive Substances Product Overview
Table 103. MedReleaf Australia Psychoactive Substances Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. MedReleaf Australia Business Overview
Table 105. MedReleaf Australia Recent Developments
Table 106. Global Psychoactive Substances Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Psychoactive Substances Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Psychoactive Substances Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Psychoactive Substances Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Psychoactive Substances Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Psychoactive Substances Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Psychoactive Substances Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Psychoactive Substances Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Psychoactive Substances Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Psychoactive Substances Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Psychoactive Substances Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Psychoactive Substances Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Psychoactive Substances Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Psychoactive Substances Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Psychoactive Substances Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Psychoactive Substances Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Psychoactive Substances Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Psychoactive Substances
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Psychoactive Substances Market Size (M USD), 2019-2030
Figure 5. Global Psychoactive Substances Market Size (M USD) (2019-2030)
Figure 6. Global Psychoactive Substances Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Psychoactive Substances Market Size by Country (M USD)
Figure 11. Psychoactive Substances Sales Share by Manufacturers in 2023
Figure 12. Global Psychoactive Substances Revenue Share by Manufacturers in 2023
Figure 13. Psychoactive Substances Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Psychoactive Substances Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Psychoactive Substances Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Psychoactive Substances Market Share by Type
Figure 18. Sales Market Share of Psychoactive Substances by Type (2019-2024)
Figure 19. Sales Market Share of Psychoactive Substances by Type in 2023
Figure 20. Market Size Share of Psychoactive Substances by Type (2019-2024)
Figure 21. Market Size Market Share of Psychoactive Substances by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Psychoactive Substances Market Share by Application
Figure 24. Global Psychoactive Substances Sales Market Share by Application (2019-2024)
Figure 25. Global Psychoactive Substances Sales Market Share by Application in 2023
Figure 26. Global Psychoactive Substances Market Share by Application (2019-2024)
Figure 27. Global Psychoactive Substances Market Share by Application in 2023
Figure 28. Global Psychoactive Substances Sales Growth Rate by Application (2019-2024)
Figure 29. Global Psychoactive Substances Sales Market Share by Region (2019-2024)
Figure 30. North America Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Psychoactive Substances Sales Market Share by Country in 2023
Figure 32. U.S. Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Psychoactive Substances Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Psychoactive Substances Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Psychoactive Substances Sales Market Share by Country in 2023
Figure 37. Germany Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Psychoactive Substances Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Psychoactive Substances Sales Market Share by Region in 2023
Figure 44. China Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Psychoactive Substances Sales and Growth Rate (Kilotons)
Figure 50. South America Psychoactive Substances Sales Market Share by Country in 2023
Figure 51. Brazil Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Psychoactive Substances Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Psychoactive Substances Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Psychoactive Substances Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Psychoactive Substances Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Psychoactive Substances Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Psychoactive Substances Market Share Forecast by Type (2025-2030)
Figure 65. Global Psychoactive Substances Sales Forecast by Application (2025-2030)
Figure 66. Global Psychoactive Substances Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Psychoactive Substances
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Psychoactive Substances Market Size (M USD), 2019-2030
Figure 5. Global Psychoactive Substances Market Size (M USD) (2019-2030)
Figure 6. Global Psychoactive Substances Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Psychoactive Substances Market Size by Country (M USD)
Figure 11. Psychoactive Substances Sales Share by Manufacturers in 2023
Figure 12. Global Psychoactive Substances Revenue Share by Manufacturers in 2023
Figure 13. Psychoactive Substances Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Psychoactive Substances Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Psychoactive Substances Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Psychoactive Substances Market Share by Type
Figure 18. Sales Market Share of Psychoactive Substances by Type (2019-2024)
Figure 19. Sales Market Share of Psychoactive Substances by Type in 2023
Figure 20. Market Size Share of Psychoactive Substances by Type (2019-2024)
Figure 21. Market Size Market Share of Psychoactive Substances by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Psychoactive Substances Market Share by Application
Figure 24. Global Psychoactive Substances Sales Market Share by Application (2019-2024)
Figure 25. Global Psychoactive Substances Sales Market Share by Application in 2023
Figure 26. Global Psychoactive Substances Market Share by Application (2019-2024)
Figure 27. Global Psychoactive Substances Market Share by Application in 2023
Figure 28. Global Psychoactive Substances Sales Growth Rate by Application (2019-2024)
Figure 29. Global Psychoactive Substances Sales Market Share by Region (2019-2024)
Figure 30. North America Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Psychoactive Substances Sales Market Share by Country in 2023
Figure 32. U.S. Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Psychoactive Substances Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Psychoactive Substances Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Psychoactive Substances Sales Market Share by Country in 2023
Figure 37. Germany Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Psychoactive Substances Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Psychoactive Substances Sales Market Share by Region in 2023
Figure 44. China Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Psychoactive Substances Sales and Growth Rate (Kilotons)
Figure 50. South America Psychoactive Substances Sales Market Share by Country in 2023
Figure 51. Brazil Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Psychoactive Substances Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Psychoactive Substances Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Psychoactive Substances Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Psychoactive Substances Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Psychoactive Substances Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Psychoactive Substances Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Psychoactive Substances Market Share Forecast by Type (2025-2030)
Figure 65. Global Psychoactive Substances Sales Forecast by Application (2025-2030)
Figure 66. Global Psychoactive Substances Market Share Forecast by Application (2025-2030)
